semaglutide and elevated liver enzymes The effect of on in subjects with obesity alanine aminotransferase: data from a randomized phase 2 trial The effect of semaglutide on

Roughly 1 in 10 people carry a genetic variant that meaningfully blunts GLP-1 response

Learn more about managing side effects, nutrition gaps, and access helpful resources

Patients on pemvidutide experienced only 21.9% of weight loss attributable to lean mass

Diarrhea affects up to 20% of people taking semaglutide during the first weeks of treatment

Sensitivity analyses showed consistent results, including restricting outcomes to inpatient visits, conducting an intention-to-treat analysis, applying a prevalent new user design, and substituting SGLT2 inhibitors with dipeptidyl peptidase-4 (DPP4) inhibitors as the active comparator